Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-α

Biomedical Research

Volumn 29, Issue 2, 2008, Pages 99-103

  Suzuki, Takahiro ^a   Sato, Fuyuki ^a   Kondo, Jun ^a   Liu, Yang ^a   Kusumi, Tomomi ^a   Fujimoto, Katsumi ^b   Kato, Yukio ^b   Sato, Tatsusuke ^c   Kijima, Hiroshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; PER1 PROTEIN; PER3 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; PANCREAS CANCER; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44449100654     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.29.99     Document Type: Article

References (27)

1. Balsalobre A, Damiola F and Schibler U (1998) A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93, 917-919
2. Burrow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S and Beckman BS (1998) Differences in suscepitibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 21, 4940-4946.
3. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T and Fontana A (2007) TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 104, 12843-12848.
4. Fazal S and Saif MW (2007) Supportive and palliative care of pancreatic cancer. J Pancreatol 8, 240-253.
5. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, Takahashi JS and Weitz CJ (1998) Role of the CLOCK protein in the mammalian circadian mechanism. Science 280, 1548-1549.
6. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D and Koeffler P (2006) The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22, 375-382.
7. Griffin EA Jr, Staknis D and Weitz CJ (1999) Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. Science 286, 768-771.
8. Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y and Honma K (2002) Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419, 841-844.
9. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Gulliaume G and Halberg F (2006) Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97, 589-596.
10. Kawamoto T, Noshiro M, Sato F, Maemura K, Takeda N, Nagai R, Iwata T, Fujimoto K, Furukawa M, Miyazaki K, Honma S, Homna K and Kato Y (2004) A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. Biochem Biophys Res Commun 313, 117-124.
11. Kijima H, Yamazaki H, Nakamura M, Scanlon KJ, Osamura RY and Ueyama Y (2004) Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer. Int J Oncol 24, 559-564.
12. Korc M (1998) Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 7, 25-41.
13. Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S and Shimeno H (2003) A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63, 7277-7283.
14. Kuninaka S, Yano T, Yokoyama H, Fukuyama Y, Terazaki Y, Uehara T, Kanematsu T, Asoh H and Ichinose Y (2000) Direct influences of pro-inflammatory cytokines (IL-1β, TNF-α and IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine 12, 8-11.
15. Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Nørgaard P and Moses HL (2000) Salicylate-induced growth arrest is associated with inhibition of p70sók and down-regulation of c-myc, cyclin D1, cychn A, and proliferating cell nuclear antigen. J Biol Chem 275, 38261-38267.
16. Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ and Shepard HM (1987) Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma. Cancer Res 47, 5382-5385.
17. Lideståhl A, Permert J, Linder S, Bylund H, Edsborg N and Lind P (2006) Efficacy of systemic therapy in advanced pancreatic carcinoma. Acta Oncol 45, 136-143.
18. Maeno K, Masuda A, Yanagisawa K, Konishi H, Osada H, Saito T, Ueda R and Takahashi T (2006) Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers. Oncogene 25, 271-277.
19. Reppert SM and Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418, 935-941.
20. Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, Kondo J, Koyanagi S, Noshiro M, Yoshida H, Kusumi T, Kato Y and Kijima H (2008) Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells, 13, 131-144.
21. Sato T, Yamauchi N, Sasaki H, Takahashi M, Okamoto T, Sakamaki S, Watanabe N and Niitsu Y (1998) An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration. Cancer Res 58, 1677-1683.
22. Stephens LA, Thomas HE, Ming L, Grell M, Darwiche R, Volodin L and Kay TW (1999) Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells. Endocrinology 140, 3219-3227.
23. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr and Shepard HM (1985) Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945.
24. Welsch T, Kleeff J and Friess H (2007) Molecular pathogenesis of pancreatic cancer: advances and challenges. Curr Mol Med 7, 504-521.
25. Yang H, Ara AI, Magilnick N, Xia M, Ramam K, Chen H, Lee TD, Mato JM and Lu SC (2008) Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in Hepatoma cells. Gastroenterology, 134, 281-291.
26. Yeh JJ and Der CJ (2007) Targeting signal transduction in pancreatic cancer treatment. Expert Opin Ther Targets 11, 673-694.
27. Zhang S, Lin ZN, Yang CF, Shi Y, Ong CN and Shen HM (2004) Suppressed NF-κB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-α-induced apoptosis in human cancer cells. Carcinogenesis 25, 2191-2199.